HOME >> BIOLOGY >> NEWS
Battle of the sexes leads to evolutionary arms race

Boxes of chocolate and Valentine cards won't get you far in the animal world where courting is considerably tougher than it is for humans. New research by evolutionary biologists from the University of Toronto and the University of Uppsala in Sweden confirm earlier beliefs that an evolutionary "battle of the sexes" can lead to a biological arms race between males and females.

The study, to be published in the Feb. 14 issue of Nature, unveils for the first time a sexual "arms race" in a group of insects - the water strider. Professors Locke Rowe of the University of Toronto's zoology department and Goran Arnqvist of the University of Uppsala in Sweden offer a new and quite different look at the fundamental conflicts of interest between the sexes.

"Males and females of most animal species look and behave very differently," says Rowe. "Males are often provided with various distinct traits like the bright colours of a peacock's feathers, for example. Females, however, aren't easily impressed. These elaborate traits in males have traditionally been explained as evolutionary consequences of females searching for good fathers for their offspring."

The key to their research lies in the fact that males and females play very different roles in reproduction. What is best for one sex is rarely best for the other, leading to a range of sexual conflicts, says Rowe. "Males of most animal species benefit from mating often with as many partners as possible while females, who are already mated, lose from mating too much. Males, therefore, seek to 'convince' females to mate while females evolve resistance measures to foil the male's mating attempts."

The traits which males use in these conflicts vary, ranging from elaborate ornaments to grasping structures that make it difficult for females to escape. The result of such sexual conflict is, in theory, an "arms race" between the sexes whereby male persistence is matched by female resistance. Such arms rac
'"/>

Contact: Janet Wong
jf.wong@utoronto.ca
416-978-6974
University of Toronto
13-Feb-2002


Page: 1 2

Related biology news :

1. Battle between bubbles might have started evolution
2. AAAS hosts Battle of the Brains to choose area student for international competition
3. Battle of the DNA bulge may help thwart cancer
4. Battle lasers
5. System failure to blame for Walkerton, North Battleford outbreaks, says U of T study
6. Researchers working to devise plan for Palo Alto Battlefield Restoration
7. Battle of the sexes leads to a biological arms race
8. Battle to save last stronghold of the red squirrel
9. Baby Dolphin "Little Orphan Annie" Loses Battle For Her Life
10. Late Blight Battle Goes Online, Marking 150 Year Struggle Since Irish Potato Famine
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Battle the sexes leads evolutionary arms race

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: